Medtronic (1MDT) Stock Statistics & Valuation Metrics
Total Valuation
Medtronic has a market cap or net worth of EUR 110.57B. The enterprise value is EUR 129.69B.
- Market Cap
- EUR 110.57B
- Enterprise Value
- EUR 129.69B
Share Statistics
Medtronic has 1,279,169,900 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,279,169,900
- Owned by Insiders
- 0.07%
- Owned by Institutions
- 51.28%
Financial Efficiency
Medtronic’s return on equity (ROE) is 0.10 and return on invested capital (ROIC) is 6.13%.
- Return on Equity (ROE)
- 0.10
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 6.13%
- Return on Capital Employed (ROCE)
- 0.08
- Revenue Per Employee
- 382.78K
- Profits Per Employee
- 50.53K
- Employee Count
- 95,000
- Asset Turnover
- 0.39
- Inventory Turnover
- 2.14
Valuation Ratios
The current PE Ratio of Medtronic is 23.60. Medtronic’s PEG ratio is 1.86.
- PE Ratio
- 23.60
- PS Ratio
- 3.29
- PB Ratio
- 2.46
- Price to FCF
- 20.14
- Price to Operating Cash Flow
- 15.38
- PEG Ratio
- 1.86
Income Statement
In the last 12 months, Medtronic had revenue of 36.36B and earned 4.80B in profits. Earnings per share was 3.75.
- Revenue
- 36.36B
- Gross Profit
- 23.64B
- Operating Income
- 6.47B
- Pretax Income
- 6.14B
- Net Income
- 4.80B
- EBITDA
- 9.81B
- Earnings Per Share (EPS)
- 3.75
Cash Flow
In the last 12 months, operating cash flow was 8.04B and capital expenditures -1.90B, giving a free cash flow of 6.13B billion.
- Operating Cash Flow
- 8.04B
- Free Cash Flow
- 6.13B
- Free Cash Flow per Share
- 4.79
Dividends & Yields
Medtronic pays an annual dividend of ―, resulting in a dividend yield of 2.88%
- Dividend Per Share
- ―
- Dividend Yield
- 2.88%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 4.97%
- Earnings Yield
- 4.23%
Stock Price Statistics
- Beta
- 0.13
- 52-Week Price Change
- 9.89%
- 50-Day Moving Average
- 80.36
- 200-Day Moving Average
- 75.03
- Relative Strength Index (RSI)
- 68.05
- Average Volume (3m)
- 182
Important Dates
Medtronic upcoming earnings date is Nov 24, 2026, TBA (Not Confirmed).
- Last Earnings Date
- Sep 01, 2026
- Next Earnings Date
- Nov 24, 2026
- Ex-Dividend Date
- ―
Financial Position
Medtronic as a current ratio of 2.13, with Debt / Equity ratio of 56.53%
- Current Ratio
- 2.13
- Quick Ratio
- 1.62
- Debt to Market Cap
- 0.26
- Net Debt to EBITDA
- 2.65
- Interest Coverage Ratio
- 9.04
Taxes
In the past 12 months, Medtronic has paid 1.30B in taxes.
- Income Tax
- 1.30B
- Effective Tax Rate
- 0.21
Enterprise Valuation
Medtronic EV to EBITDA ratio is 14.73, with an EV/FCF ratio of 24.45.
- EV to Sales
- 3.99
- EV to EBITDA
- 14.73
- EV to Free Cash Flow
- 24.45
- EV to Operating Cash Flow
- 18.66
Balance Sheet
Medtronic has EUR 8.82B in cash and marketable securities with EUR 28.15B in debt, giving a net cash position of -EUR 19.33B billion.
- Cash & Marketable Securities
- EUR 8.82B
- Total Debt
- EUR 28.15B
- Net Cash
- -EUR 19.33B
- Net Cash Per Share
- -EUR 15.11
- Tangible Book Value Per Share
- -EUR 2.01
Margins
Gross margin is 66.69%, with operating margin of 18.08%, and net profit margin of 13.93%.
- Gross Margin
- 66.69%
- Operating Margin
- 18.08%
- Pretax Margin
- 17.59%
- Net Profit Margin
- 13.93%
- EBITDA Margin
- 27.11%
- EBIT Margin
- 19.52%
Analyst Forecast
The average price target for Medtronic is EUR 92.13, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 92.13
- Price Target Upside
- 5.73% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 19
- Revenue Growth Forecast
- 3.13%
- EPS Growth Forecast
- 5.28%
Scores
- Smart Score
- 9
- AI Score
- ―
